Alzheimer’s Disease

The Rotterdam study: associations between plasma NfL and neurodegenerative disease

AAIC 2021 highlights in the vascular space

Microglial gene expression in mouse models of tauopathy

Plasma p-Tau181 and p-Tau231 offer complementary information in Alzheimer’s

A new Aβ PET-based staging method

Expanding research populations and moving towards action to mitigate health disparities

The contribution of vascular disease to cognitive impairment and Alzheimer’s pathology

Developing gingipain inhibitors for the treatment of Alzheimer’s disease

The extended Network Diffusion Model: introducing amyloid-tau interactions

APP/PS1 mutations associated with earlier cognitive decline in offspring rodents

Investigating plasma biomarkers in the real-world setting

Contextual disadvantage as a major independent factor in brain health disparities

The ability of plasma P-tau231 to detect preclinical Alzheimer’s disease

Investigating novel plasma-based P-tau biomarkers

The importance of new methods for monitoring tau pathology

COR388: a novel approach to treating Alzheimer’s based on the gingipain hypothesis